Published in J Biol Chem on May 22, 2008
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev (2010) 2.10
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol (2011) 1.81
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci (2010) 1.78
Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol (2010) 1.73
Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem J (2011) 1.49
Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2. Gastroenterology (2009) 1.33
Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol (2012) 1.31
The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem (2009) 1.28
Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem (2009) 1.27
Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol (2014) 1.21
Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3. J Biol Chem (2010) 1.17
Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site. Nat Chem Biol (2011) 1.16
Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J (2009) 1.07
Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. Br J Pharmacol (2009) 1.01
Fatty acid amide signaling molecules. Bioorg Med Chem Lett (2010) 0.98
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Mediat (2011) 0.96
Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals. Bioorg Med Chem Lett (2008) 0.95
Orphan endogenous lipids and orphan GPCRs: a good match. Prostaglandins Other Lipid Mediat (2009) 0.92
Peripheral neural targets in obesity. Br J Pharmacol (2012) 0.92
N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. Br J Pharmacol (2010) 0.91
A GPR18-based signalling system regulates IOP in murine eye. Br J Pharmacol (2013) 0.90
P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion. Am J Physiol Gastrointest Liver Physiol (2009) 0.88
N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways. Mol Pharmacol (2012) 0.88
So what do we call GPR18 now? Br J Pharmacol (2012) 0.87
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration. J Mol Signal (2012) 0.86
N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. Br J Pharmacol (2010) 0.86
Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. Acta Pharmacol Sin (2010) 0.86
Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain. Int J Mol Sci (2010) 0.83
Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules. J Biol Chem (2012) 0.79
A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates. PLoS One (2013) 0.79
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. Front Pharmacol (2014) 0.78
N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs. Br J Pharmacol (2013) 0.78
Intercellular Lipid Mediators and GPCR Drug Discovery. Biomol Ther (Seoul) (2013) 0.77
Targeting TRPV3 for the Development of Novel Analgesics. Open Pain J (2013) 0.77
Feeding-dependent activation of enteric cells and sensory neurons by lymphatic fluid: evidence for a neurolymphocrine system. Am J Physiol Gastrointest Liver Physiol (2014) 0.76
Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the β2 subunit of GABAA receptors? PeerJ (2013) 0.76
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregation. Thromb Haemost (2012) 0.75
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18. Sci Rep (2016) 0.75
Genetic and pharmacological evidence for low-abundance TRPV3 expression in primary vagal afferent neurons. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 16.31
Improved protein-ligand docking using GOLD. Proteins (2003) 7.94
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
A capsaicin-receptor homologue with a high threshold for noxious heat. Nature (1999) 5.85
The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A (2003) 3.24
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem (2003) 3.04
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov (2007) 2.67
GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem (2006) 2.65
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem (2001) 2.19
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem (1997) 2.01
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun (2006) 1.79
Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther (2006) 1.78
Discovery and mapping of ten novel G protein-coupled receptor genes. Gene (2001) 1.60
GPCR deorphanizations: the novel, the known and the unexpected transmitters. Trends Pharmacol Sci (2005) 1.49
MollDE: a homology modeling framework you can click with. Bioinformatics (2005) 1.40
Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal Biochem (1997) 1.31
Structure of mammalian protein geranylgeranyltransferase type-I. EMBO J (2003) 1.28
Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem Pharmacol (2004) 1.26
The identification of ligands at orphan G-protein coupled receptors. Annu Rev Pharmacol Toxicol (2004) 1.23
Membrane-proximal region of the carboxyl terminus of the gonadotropin-releasing hormone receptor (GnRHR) confers differential signal transduction between mammalian and nonmammalian GnRHRs. Mol Endocrinol (2004) 1.18
Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology (2007) 1.17
GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells. Am J Physiol Gastrointest Liver Physiol (2007) 1.13
Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis. Genomics (1997) 1.12
G protein betagamma complex translocation from plasma membrane to Golgi complex is influenced by receptor gamma subunit interaction. Cell Signal (2006) 1.07
Regulation of anandamide tissue levels by N-arachidonylglycine. Biochem Pharmacol (2002) 1.07
Cellular and molecular biology of orphan G protein-coupled receptors. Int Rev Cytol (2006) 1.03
Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons. Eur J Pharmacol (2002) 0.99
Actions of N-arachidonyl-glycine in a rat inflammatory pain model. Mol Pain (2007) 0.98
Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors. Mol Endocrinol (2007) 0.91
Distribution of branch point prenyltransferases in regions of bovine brain. J Neurochem (1995) 0.87
Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry. Drug Des Discov (2000) 0.87
New targets for neuropathic pain therapeutics. Expert Opin Ther Targets (2005) 0.82
An endocannabinoid mechanism for stress-induced analgesia. Nature (2005) 4.03
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A (2002) 3.16
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci U S A (2006) 3.06
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature (2012) 2.99
Portability of paddle motif function and pharmacology in voltage sensors. Nature (2007) 2.43
The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nat Neurosci (2012) 2.28
Voltage-sensor activation with a tarantula toxin as cargo. Nature (2005) 2.16
A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J (2002) 2.11
Proximal dominant hereditary motor and sensory neuropathy with proximal dominance association with mutation in the TRK-fused gene. JAMA Neurol (2013) 2.07
A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem (2007) 2.05
TRPC channels as STIM1-regulated store-operated channels. Cell Calcium (2007) 2.04
Transporter-mediated bile acid uptake causes Ca2+-dependent cell death in rat pancreatic acinar cells. Gastroenterology (2002) 1.91
Amygdala depotentiation and fear extinction. Proc Natl Acad Sci U S A (2007) 1.91
A protein sequence that can encode native structure by disfavoring alternate conformations. Nat Struct Biol (2002) 1.85
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci (2010) 1.78
BMAL1 shuttling controls transactivation and degradation of the CLOCK/BMAL1 heterodimer. Mol Cell Biol (2006) 1.74
Rescue of ΔF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway. Cell (2011) 1.72
Protease-activated receptor 2 exerts local protection and mediates some systemic complications in acute pancreatitis. Gastroenterology (2004) 1.72
Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway. Proc Natl Acad Sci U S A (2002) 1.67
DNA methylation increases nucleosome compaction and rigidity. J Am Chem Soc (2010) 1.67
Dynamic modulation of ANO1/TMEM16A HCO3(-) permeability by Ca2+/calmodulin. Proc Natl Acad Sci U S A (2012) 1.63
Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators. Am J Physiol Regul Integr Comp Physiol (2006) 1.62
Clinical outcomes and optimal treatment for stent fracture after drug-eluting stent implantation. J Cardiol (2009) 1.61
Solution structure and lipid membrane partitioning of VSTx1, an inhibitor of the KvAP potassium channel. Biochemistry (2005) 1.61
Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and its role in pancreatic bicarbonate secretion. Gastroenterology (2010) 1.58
Tarantula toxins interact with voltage sensors within lipid membranes. J Gen Physiol (2007) 1.58
Interactions between lipids and voltage sensor paddles detected with tarantula toxins. Nat Struct Mol Biol (2009) 1.56
Neural correlates of superior intelligence: stronger recruitment of posterior parietal cortex. Neuroimage (2005) 1.55
Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J Neurosci (2008) 1.53
Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex. Mol Cell Biol (2008) 1.52
A tarantula spider toxin, GsMTx4, reduces mechanical and neuropathic pain. Pain (2008) 1.52
Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature (2003) 1.51
Mechanosensitive nonselective cation channel facilitation by endothelin-1 is regulated by protein kinase C in arterial myocytes. Cardiovasc Res (2007) 1.48
N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem (2003) 1.48
Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc Natl Acad Sci U S A (2008) 1.46
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br J Pharmacol (2008) 1.43
Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev (2007) 1.42
Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney. J Am Soc Nephrol (2014) 1.41
Dynamic regulation of cystic fibrosis transmembrane conductance regulator by competitive interactions of molecular adaptors. J Biol Chem (2007) 1.41
A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet (2003) 1.40
Two-year clinical outcome after abciximab-coated stent implantation in patients with coronary artery disease. Circ J (2010) 1.39
The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol (2005) 1.38
NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation. Mol Cell Biol (2004) 1.37
Enhanced learning and memory in mice lacking Na+/Ca2+ exchanger 2. Neuron (2003) 1.35
A novel flavin-containing monooxygenase from Methylophaga sp strain SK1 and its indigo synthesis in Escherichia coli. Biochem Biophys Res Commun (2003) 1.35
Effects of electroacupuncture on cold allodynia in a rat model of neuropathic pain: mediation by spinal adrenergic and serotonergic receptors. Exp Neurol (2005) 1.33
Multiple bases of human intelligence revealed by cortical thickness and neural activation. J Neurosci (2008) 1.28
The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem (2009) 1.28
Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front Neuroendocrinol (2009) 1.26
Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10. J Neurochem (2005) 1.25
Solution structure and functional characterization of SGTx1, a modifier of Kv2.1 channel gating. Biochemistry (2004) 1.25
Impaired migration in the rostral migratory stream but spared olfactory function after the elimination of programmed cell death in Bax knock-out mice. J Neurosci (2007) 1.24
MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics (2007) 1.23
Clinical characteristics of primary epiploic appendagitis. J Korean Soc Coloproctol (2011) 1.21
Cystic fibrosis in Korean children:a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis. J Korean Med Sci (2005) 1.21
N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons. Mol Pharmacol (2008) 1.20
Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates. Endocrinology (2009) 1.20
Parkin ubiquitinates and promotes the degradation of RanBP2. J Biol Chem (2005) 1.19
Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med (2008) 1.19
Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol (2011) 1.18
Membrane-proximal region of the carboxyl terminus of the gonadotropin-releasing hormone receptor (GnRHR) confers differential signal transduction between mammalian and nonmammalian GnRHRs. Mol Endocrinol (2004) 1.18
Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. J Biol Chem (2002) 1.18
Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. Cell Signal (2010) 1.16
TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron (2012) 1.15
Molecular surface of tarantula toxins interacting with voltage sensors in K(v) channels. J Gen Physiol (2004) 1.14
Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis. Eur Heart J (2009) 1.14
Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim Biophys Acta (2011) 1.13
Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. J Cell Sci (2010) 1.12
Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J Lipid Res (2010) 1.12
Coumarin-derived Cu(2+)-selective fluorescence sensor: synthesis, mechanisms, and applications in living cells. J Am Chem Soc (2009) 1.10
Clinical and histological features of nonalcoholic fatty liver disease in children. Dig Dis Sci (2009) 1.09
Novel endogenous N-acyl glycines identification and characterization. Vitam Horm (2009) 1.09
T-type Ca2+ channels as therapeutic targets in the nervous system. Curr Opin Pharmacol (2008) 1.08
Regulation of anandamide tissue levels by N-arachidonylglycine. Biochem Pharmacol (2002) 1.07
The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J Biol Chem (2006) 1.06
CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. J Leukoc Biol (2007) 1.06
Rapid activation of CLOCK by Ca2+-dependent protein kinase C mediates resetting of the mammalian circadian clock. EMBO Rep (2007) 1.06
Membrane-delimited coupling of TRPV1 and mGluR5 on presynaptic terminals of nociceptive neurons. J Neurosci (2009) 1.06
The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3. J Biol Chem (2002) 1.06
Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cell Signal (2007) 1.05
Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A. Biochem J (2004) 1.05
Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J Proteome Res (2009) 1.05